Genomics analytics platform developer Sophia Genetics has gone public ten years after it was co-founded by researchers from EMBL, Stanford and University of Geneva
Sophia Genetics, a Switzerland-based genomics analytics platform operator co-founded by researchers from EMBL, Stanford University and University of Geneva, has amassed $234m in an initial public offering. Sophia priced 13 million shares at $18 per share, the midpoint of its initial $17 to $19m price range. The shares are currently priced at $19.48 at the…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
